Scientists believe they have discovered a way to “steer” the immune system to kill cancers.
Researchers at University College, London have developed a way of finding unique markings within a tumour – its “Achilles heel” – allowing the body to target the disease.
But the personalised method, reported in Science journal, would be expensive and has not yet been tried in patients.
Experts said the idea made sense but could be more complicated in reality.
However, the researchers, whose work was funded by Cancer Research UK, believe their discovery could form the backbone of new treatments and hope to test it in patients within two years.
They believe by analysing the DNA, they’ll be able to develop bespoke treatment.
People have tried to steer the immune system to kill tumours before, but cancer vaccines have largely flopped.
One explanation is that they are training the body’s own defences to go after the wrong target.
The problem is cancers are not made up of identical cells – they are a heavily mutated, genetic mess and samples at different sites within a tumour can look and behave very differently.
They grow a bit like a tree with core “trunk” mutations, but then mutations that branch off in all directions. It is known as cancer heterogeneity.
The international study developed a way of discovering the “trunk” mutations that change antigens – the proteins that stick out from the surface of cancer cells.
Professor Charles Swanton, from the UCL Cancer Institute, added: “This is exciting. Now we can prioritise and target tumour antigens that are present in every cell – the Achilles heel of these highly complex cancers.
The Latest on: Cancer research
via Google News
The Latest on: Cancer research
- Buddies Embark on 500-Mile Pack Trip for Cancer Researchon June 27, 2020 at 5:21 am
Three Montana buddies decided to turn a fun trip into the state’s backcountry into a cause, raising money for research on cancer, which has claimed the lives of friends and family members they loved.
- Virginia Tech cancer researcher Carla Finkielstein to join Fralin Biomedical Research Instituteon June 26, 2020 at 9:10 pm
Carla Finkielstein, a cancer researcher and an associate professor of biological sciences in Virginia Tech’s College of Science, will join the Fralin Biomedical Research Institute at VTC on July 1.
- AnHeart Therapeutics Announces Acceptance of Taletrectinib Phase 1 Data for Publication in Clinical Cancer Researchon June 26, 2020 at 5:12 pm
“We are honored to have our study selected for publication in Clinical Cancer Research. There is a significant unmet need for next generation tyrosine kinase inhibitors to overcome resistance ...
- Frederick National Laboratory for Cancer Researchon June 26, 2020 at 9:40 am
HPC industry veteran Jack Collins, long-time fixture in the scientific supercomputing community, has seen it all in HPC, from the days when his input/output device for storing integrals was nine-track ...
- AIkido Pharma Inc. Provides Update to Machine Learning Pancreatic Cancer Researchon June 26, 2020 at 7:38 am
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced an update to its machine learning driven pancreatic cancer research.
- Men in England and Wales miss out on abiraterone as first-line treatment for advanced prostate canceron June 26, 2020 at 7:14 am
The Institute of Cancer Research, London, has expressed disappointment at the decision by NICE not to recommend abiraterone as a first-line treatment on the NHS for newly diagnosed, advanced prostate ...
- Highly acidic foods can increase breast cancer recurrence and mortality among past smokerson June 26, 2020 at 5:12 am
Fresh and processed meats, cheese, eggs, sugary food, soft drinks, and grains are acid-producing foods. For cancer survivors who have a reduced capacity to process such foods that produce sulfuric, ...
- COVID-19 and cancer researchon June 26, 2020 at 12:27 am
The COVID-19 pandemic has had a devastating effect on human lives and society. The accompanying editorial summarises some of the major effects on cancer patients and impacts on cancer research. These ...
- Montana cowboys start horseback trip to raise cancer research fundson June 25, 2020 at 12:01 pm
Keagan Stroop, Troy Hennes and Harry Green plan to begin their 45-day ride at Bannock Pass in the Beaverhead-Dearlodge National Forest.
- Fred Hutchinson Cancer Research Center names new board chair and adds trusteeson June 25, 2020 at 10:46 am
The Fred Hutchinson Cancer Research Center named a new chair of its board of trustees, Kathy Surace-Smith, a senior vice president at NanoString Technologies and life sciences industry veteran who ...
via Bing News